View this in your browser.

The Niche Stem Cell & Regen Med Website

We have a new post today!
Unsubscribe | Manage subscription
The Niche
Stem Cell & Regenerative Medicine Resource
1 Shields Ave
Davis, CA 95616

Weekly reads: Vertex, stem cells for MS, Athersys, 900-day paper review at Nature
Vertex Pharmaceuticals has a lot going for it right now on the cell therapy front. For instance, they have the strongest type 1 diabetes cell therapy pipeline after some recent acquisitions. Still it's not a simple matter to succeed in the cell therapy space even with one therapy for one targeted disease. Trials are tough to run, expensive, and groups …
“While still early, these results support the continued progression of our VX-880 clinical studies, as well as future studies using our encapsulated islet cells, which hold the potential to be used without the need for immunosuppression,” said Bastiano Sanna, Ph.D., executive vice president and chief of cell and genetic therapies at Vertex.